NCT00796250: Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732) |
|
|
| Terminated | 3 | 9 | NA | Infliximab, Remicade, SCH 215596, AZA, Imuran, Placebo Prednisolone, Placebo, Prednisolone, Pediapred, Placebo Infliximab | Merck Sharp & Dohme LLC | Crohn's Disease | 01/05 | 01/05 | | |
